| European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease JF Rahier, S Ben-Horin, Y Chowers, C Conlon, P De Munter, G D'Haens, ... Journal of Crohn's and Colitis 3 (2), 47-91, 2009 | 693 | 2009 |
| Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study NA Kennedy, GA Heap, HD Green, B Hamilton, C Bewshea, GJ Walker, ... The lancet Gastroenterology & hepatology 4 (5), 341-353, 2019 | 577 | 2019 |
| Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum D Agranoff, D Fernandez-Reyes, MC Papadopoulos, SA Rojas, ... The Lancet 368 (9540), 1012-1021, 2006 | 343 | 2006 |
| Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 BS Sheena, L Hiebert, H Han, H Ippolito, M Abbasi-Kangevari, ... The lancet Gastroenterology & hepatology 7 (9), 796-829, 2022 | 328 | 2022 |
| Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international … I Roberts, H Shakur-Still, A Afolabi, A Akere, M Arribas, A Brenner, ... The Lancet 395 (10241), 1927-1936, 2020 | 315 | 2020 |
| HLA-DQA1* 05 carriage associated with development of anti-drug antibodies to infliximab and adalimumab in patients with Crohn’s disease A Sazonovs, NA Kennedy, L Moutsianas, GA Heap, DL Rice, M Reppell, ... Gastroenterology 158 (1), 189-199, 2020 | 313 | 2020 |
| British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic NA Kennedy, GR Jones, CA Lamb, R Appleby, I Arnott, RM Beattie, ... Gut 69 (6), 984-990, 2020 | 291 | 2020 |
| Preoperative steroid use and risk of postoperative complications in patients with inflammatory bowel disease undergoing abdominal surgery V Subramanian, S Saxena, JY Kang, RCG Pollok Official journal of the American College of Gastroenterology| ACG 103 (9 …, 2008 | 270 | 2008 |
| Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD NA Kennedy, S Lin, JR Goodhand, N Chanchlani, B Hamilton, ... Gut 70 (10), 1884-1893, 2021 | 259 | 2021 |
| Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 R Sharma, M Abbasi-Kangevari, R Abd-Rabu, H Abidi, E Abu-Gharbieh, ... The lancet Gastroenterology & hepatology 7 (7), 627-647, 2022 | 249 | 2022 |
| Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn's disease (METRIC): a … SA Taylor, S Mallett, G Bhatnagar, R Baldwin-Cleland, S Bloom, A Gupta, ... The lancet Gastroenterology & hepatology 3 (8), 548-558, 2018 | 201 | 2018 |
| Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab NA Kennedy, JR Goodhand, C Bewshea, R Nice, D Chee, S Lin, ... Gut 70 (5), 865-875, 2021 | 179 | 2021 |
| Interferon gamma induces enterocyte resistance against infection by the intracellular pathogen Cryptosporidium parvum RCG Pollok, MJG Farthing, M Bajaj-Elliott, IR Sanderson, V McDonald Gastroenterology 120 (1), 99-107, 2001 | 140 | 2001 |
| Association of genetic variants in NUDT15 with thiopurine-induced myelosuppression in patients with inflammatory bowel disease GJ Walker, JW Harrison, GA Heap, MD Voskuil, V Andersen, ... Jama 321 (8), 773-785, 2019 | 139 | 2019 |
| Mannose-binding lectin is a component of innate mucosal defense against Cryptosporidium parvum in AIDS P Kelly, DL Jack, A Naeem, B Mandanda, RCG Pollok, NJ Klein, ... Gastroenterology 119 (5), 1236-1242, 2000 | 139 | 2000 |
| The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019 G Castelpietra, AKS Knudsen, EE Agardh, B Armocida, M Beghi, KM Iburg, ... The Lancet Regional Health–Europe 16, 2022 | 137 | 2022 |
| Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel disease MH Jen, S Saxena, A Bottle, P Aylin, RCG Pollok Alimentary pharmacology & therapeutics 33 (12), 1322-1331, 2011 | 135 | 2011 |
| Systematic review of postoperative complications in patients with inflammatory bowel disease treated with immunomodulators V Subramanian, RCG Pollok, JY Kang, D Kumar Journal of British Surgery 93 (7), 793-799, 2006 | 134 | 2006 |
| Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1 NC Galles, PY Liu, RL Updike, N Fullman, J Nguyen, S Rolfe, AN Sbarra, ... The Lancet 398 (10299), 503-521, 2021 | 119 | 2021 |
| Clinical features and HLA association of 5-aminosalicylate (5-ASA)-induced nephrotoxicity in inflammatory bowel disease GA Heap, K So, M Weedon, N Edney, C Bewshea, A Singh, V Annese, ... Journal of Crohn's and Colitis 10 (2), 149-158, 2016 | 114 | 2016 |
Professor Sonia SaxenaProfessor of Primary Care, Imperial College London在 imperial.ac.uk 的电子邮件经过验证
